QUINTA-ANALYTICA
Roman Grunt has a diverse work experience spanning over several companies. Roman began their career as an Auditor at Ernst & Young in 1996, working in both Switzerland and the Czech Republic until 1999. From 2000 to 2007, they served as the Head of Group Controlling at Zentiva, overseeing the development and operation of the controlling department across 15 countries. Roman then went on to hold various roles at sanofi-aventis and CEZ in 2010 before becoming the General Manager at Farmak, a.s. in 2013. Currently, they are the CEO of Quinta-Analytica, a company that offers a range of R&D and regulatory services for the pharmaceutical industry.
Roman Grunt completed their education with a Master's degree in Economics of the automotive industry from Czech Technical University in Prague. Roman pursued this degree from 1991 to 1997. Prior to that, from 2005 to 2006, they attended London Business School and earned a certification in corporate finance.
This person is not in any teams
This person is not in any offices
QUINTA-ANALYTICA
Quinta is a GCP/GLP/GMP-certified, EMA and FDA-inspected European CRO offering in-house clinical testing, pharmaceutical analysis, CMC and R&D. Quinta specializes in clinical studies, bioanalytics, method development and quality control for both small and large molecules, human and veterinary IMPs as well as generics. We provide unrivaled expertise to worldwide pharmaceutical and biotechnological clients across the entire pharma spectrum. Quinta is part of the Conscio group with headquarters in Munich, Germany, laboratories in Czechia, Austria, Slovakia, Germany and offices in the USA. Our main service areas include: 1) Clinical Testing: With 2 in-house clinical units providing BE/BA/PK studies, with capacity for 60+40 beds. 2) Bioanalytical Testing: GLP/GCP solutions for preclinical & clinical studies, small & large molecules, BE/BA/PK. 3) Research & Development: Analytical R&D, impurities, extractables & leachables, degradation, trace studies. 4) Pharmaceutical Quality Control: GMP quality control, batch testing, stabilities, HAPIs, inhalation, API sourcing. 5) Microbiology: GMP sterile & non-sterile testing, microbial/water analyses, endotoxins, antibiotics & vitamins. 6) Biopharmaceutical Quality Control: GLP/GMP bioanalysis, CMC, characterizations of peptide & protein IMPs, biosimilars. Quinta was founded in 1997 and has been successfully inspected by FDA more than 10 times. Quinta is headquartered in Prague, Czech Republic.